3-V Biosciences
Industry: Company
DescriptionHeadquarters: Palo Alto, CA Founded: 2006
3-V Biosciences List of Employees There's an exhaustive list of past and present employees! Get comprehensive information on the number of employees at 3-V Biosciences. You can filter them based on skills, years of employment, job, education, department, and prior employment.
3-V Biosciences Salaries. You can even request information on how much does 3-V Biosciences pay if you want to. Learn about salaries, pros and cons of working for 3-V Biosciences directly from the past employees.
Find People by Employers You can rekindle an old relationship, reconnect with a long-lost friend, former boss, business acquaintance who might be useful in your new line of work. With our employee database, the possibilities are endless. All you have to do is type in a couple of keywords and we'll bring you the exact information you wanted!
19 3-V Biosciences employees in database. Find out everything there's to know about 3-V Biosciences employees. We offer you a great deal of unbiased information from the internal database, personal records, and many other details that might be of interest to you.
3-V Biosciences Employees
Employee
Years
Job
Industry
Claudia Rubio Claudia Rubio's 3-V Biosciences Experience June 2015 - Present
Job Scientist at 3V Biosciences
Industry Research
Experience
3-V Biosciences June 2015 - Present
Novartis Institutes for Biomedical Research 2011 - May 2015
UCSF, Dr. Peter Walter's Laboratory September 2002 - August 2010
UCSF School of Pharmacy March 2004 - June 2004
Fred Hutchinson Cancer Research Center, Dr. Gerald Smith January 2000 - January 2002
Fred Hutchinson Cancer Research Center, Dr. Claudio Anasetti January 1999 - January 2000
Fred Hutchinson Cancer Research Center, Dr. Maxine Linial June 1997 - January 1999
University of Washington Department of Aerospace and Energetics June 1996 - December 1997
Skills
Cell Biology, Biochemistry, Molecular Biology, Cell Culture, FACS, Protein Purification, Kinase Expertise, Microscopy, Next Generation..., DNA sequencing, Genetics, DNA, Cancer, In Vitro, Flow Cytometry, Fluorescence Microscopy, Protein Expression, Immunology, DNA Sequencing
Education
University of California, San Francisco 2002 — 2010
PhD, Biochemistry and Molecular Biology
University of Washington 1995 — 1999
B.S., Microbiology
3-V Biosciences June 2015 - Present
Novartis Institutes for Biomedical Research 2011 - May 2015
UCSF, Dr. Peter Walter's Laboratory September 2002 - August 2010
UCSF School of Pharmacy March 2004 - June 2004
Fred Hutchinson Cancer Research Center, Dr. Gerald Smith January 2000 - January 2002
Fred Hutchinson Cancer Research Center, Dr. Claudio Anasetti January 1999 - January 2000
Fred Hutchinson Cancer Research Center, Dr. Maxine Linial June 1997 - January 1999
University of Washington Department of Aerospace and Energetics June 1996 - December 1997
Skills
Cell Biology, Biochemistry, Molecular Biology, Cell Culture, FACS, Protein Purification, Kinase Expertise, Microscopy, Next Generation..., DNA sequencing, Genetics, DNA, Cancer, In Vitro, Flow Cytometry, Fluorescence Microscopy, Protein Expression, Immunology, DNA Sequencing
Education
University of California, San Francisco 2002 — 2010
PhD, Biochemistry and Molecular Biology
University of Washington 1995 — 1999
B.S., Microbiology
Doug Buckley Doug Buckley's 3-V Biosciences Experience February 2012 - Present
Job Vice President, Biology, 3V Biosciences
Industry Biotechnology
Experience
3-V Biosciences February 2012 - Present
Astia 2012 - Present
Woodside Capital Partners 2011 - Present
Exelixis Inc. October 1997 - April 2011
Scios Inc. (formerly California Biotechnology) 1986 - 1997
UCSF Medical Center 1977 - 1982
Skills
Lifesciences, Biochemistry, Protein Chemistry, Drug Development, Clinical Development, Molecular Biology, Oncology, Biology, Pharmaceutical Industry, Biopharmaceuticals, Cell, Clinical Trials, Cell Biology, Technology Transfer, Cancer, Immunology, Cell Culture, Genomics, Infectious Diseases, Venture Capital
Education
University of California, San Francisco 1977 — 1981
Ph.D.
Bowdoin College 1971 — 1975
AB, Chemistry and Economics
3-V Biosciences February 2012 - Present
Astia 2012 - Present
Woodside Capital Partners 2011 - Present
Exelixis Inc. October 1997 - April 2011
Scios Inc. (formerly California Biotechnology) 1986 - 1997
UCSF Medical Center 1977 - 1982
Skills
Lifesciences, Biochemistry, Protein Chemistry, Drug Development, Clinical Development, Molecular Biology, Oncology, Biology, Pharmaceutical Industry, Biopharmaceuticals, Cell, Clinical Trials, Cell Biology, Technology Transfer, Cancer, Immunology, Cell Culture, Genomics, Infectious Diseases, Venture Capital
Education
University of California, San Francisco 1977 — 1981
Ph.D.
Bowdoin College 1971 — 1975
AB, Chemistry and Economics
Monica Fengqiu Wu Monica Fengqiu Wu's 3-V Biosciences Experience February 2011 - June 2011
Job Sr. Software Engineer at Cheetah Technologies
Industry Biotechnology
Experience
Cheetah Technologies June 2011 - Present
3-V Biosciences February 2011 - June 2011
Optivia Biotechnology November 2010 - June 2011
XenoPort, Inc. July 2002 - May 2010
Tularik October 1999 - June 2002
Skills
DTS, Databases, MySQL, Software Documentation, Perl, Oracle, Tomcat, PL/SQL, Pharmaceutical Industry, Software Development, Biotechnology, Java
Education
Sichuan Normal University 1989 — 1993
Bachelor, Computer Science
San Jose State University
Master, Computer Engineering
Cheetah Technologies June 2011 - Present
3-V Biosciences February 2011 - June 2011
Optivia Biotechnology November 2010 - June 2011
XenoPort, Inc. July 2002 - May 2010
Tularik October 1999 - June 2002
Skills
DTS, Databases, MySQL, Software Documentation, Perl, Oracle, Tomcat, PL/SQL, Pharmaceutical Industry, Software Development, Biotechnology, Java
Education
Sichuan Normal University 1989 — 1993
Bachelor, Computer Science
San Jose State University
Master, Computer Engineering
Cristiana Zaharia Cristiana Zaharia's 3-V Biosciences Experience November 2011 - August 2013
Job Associate Manager, Regulatory Affairs, CMC
Industry Biotechnology
Experience
Gilead Sciences August 2013 - Present
3-V Biosciences November 2011 - August 2013
Exelixis, Inc. January 2008 - October 2011
Exelixis June 2006 - December 2007
Merck Frosst, Canada September 2000 - May 2001
University of Waterloo May 1999 - August 1999
Skills
Drug Discovery, Medicinal Chemistry, Oncology, Drug Design, Kinases, Synthetic Organic..., Heterocyclic Chemistry, Clinical Development, Technology Transfer, ADME, Protein Chemistry, IND, In Vitro, Small Molecules, CMC Regulatory Affairs, NDA, Regulatory Strategy...
Education
University of California, San Diego 2012 — 2014
Certificate in Regulatory Affairs Essentials
UW/UCSD 2012 — 2013
Certficate in Biotechnology Project Management
University of California, Irvine 2001 — 2006
Ph.D., Chemistry
Concordia University 1997 — 2001
B.Sc., Chemistry, Honors
Gilead Sciences August 2013 - Present
3-V Biosciences November 2011 - August 2013
Exelixis, Inc. January 2008 - October 2011
Exelixis June 2006 - December 2007
Merck Frosst, Canada September 2000 - May 2001
University of Waterloo May 1999 - August 1999
Skills
Drug Discovery, Medicinal Chemistry, Oncology, Drug Design, Kinases, Synthetic Organic..., Heterocyclic Chemistry, Clinical Development, Technology Transfer, ADME, Protein Chemistry, IND, In Vitro, Small Molecules, CMC Regulatory Affairs, NDA, Regulatory Strategy...
Education
University of California, San Diego 2012 — 2014
Certificate in Regulatory Affairs Essentials
UW/UCSD 2012 — 2013
Certficate in Biotechnology Project Management
University of California, Irvine 2001 — 2006
Ph.D., Chemistry
Concordia University 1997 — 2001
B.Sc., Chemistry, Honors
Edward Connor Edward Connor's 3-V Biosciences Experience 2010 - 2012
Job Clinical Research Alliance, LLC
Industry Research
Experience
Clinical Research Alliance, LLC 2008 - Present
George Washington University School of Medicine and Health Sciences 2014 - Present
ReveraGen 2010 - 2014
George Washington University School of Medicine and Health Sciences 2008 - 2014
Children's National Medical Center 2008 - 2014
GenVec 2011 - September 2013
3-V Biosciences 2010 - 2012
MedImmune 1994 - 2008
UMD-New Jersey Medical School 1985 - 1994
Skills
Pediatrics, Clinical Trials, Immunology, Microbiology, Therapeutics, Medical Research, Vaccines, Life Sciences, Clinical Research, Regulatory Affairs, Biotechnology, Medical Devices, Infectious Diseases, Strategic Planning, Regulatory Submissions, Clinical Development, Bioethics, Research Ethics and...
Education
University of Pennsylvania School of Medicine 2009 — 2012
MBE, Bioethics/Medical Ethics
University of Rochester School of Medicine and Dentistry 1982 — 1984
Pediatric Infectious Diseases
Northwestern University - The Feinberg School of Medicine 1978 — 1982
Pediatrics
University of Pennsylvania School of Medicine 1974 — 1978
MD, Medicine
Villanova University 1970 — 1974
BS, Biology, Honors
Clinical Research Alliance, LLC 2008 - Present
George Washington University School of Medicine and Health Sciences 2014 - Present
ReveraGen 2010 - 2014
George Washington University School of Medicine and Health Sciences 2008 - 2014
Children's National Medical Center 2008 - 2014
GenVec 2011 - September 2013
3-V Biosciences 2010 - 2012
MedImmune 1994 - 2008
UMD-New Jersey Medical School 1985 - 1994
Skills
Pediatrics, Clinical Trials, Immunology, Microbiology, Therapeutics, Medical Research, Vaccines, Life Sciences, Clinical Research, Regulatory Affairs, Biotechnology, Medical Devices, Infectious Diseases, Strategic Planning, Regulatory Submissions, Clinical Development, Bioethics, Research Ethics and...
Education
University of Pennsylvania School of Medicine 2009 — 2012
MBE, Bioethics/Medical Ethics
University of Rochester School of Medicine and Dentistry 1982 — 1984
Pediatric Infectious Diseases
Northwestern University - The Feinberg School of Medicine 1978 — 1982
Pediatrics
University of Pennsylvania School of Medicine 1974 — 1978
MD, Medicine
Villanova University 1970 — 1974
BS, Biology, Honors
Allan Wagman Allan Wagman's 3-V Biosciences Experience May 2013 - Present
Job Senior Director Chemistry at 3V Biosciences
Industry Pharmaceuticals
Experience
3-V Biosciences May 2013 - Present
Blanca Pharmaceuticals, LLC, Menlo Park, CA October 2012 - Present
ASW Pharmaceutical and Biotech Consulting October 2012 - Present
NuPotential, Inc. January 2013 - April 2015
Achaogen. Inc. October 2012 - April 2013
Achaogen, Inc October 2006 - September 2012
Novartis Corp., NIBR, Emeryville, CA April 2006 - October 2006
Chiron Corporation September 1996 - April 2006
Skills
Medicinal Chemistry, Drug Discovery, Drug Design, Organic Chemistry, Organic Synthesis, Biotechnology, Pharmaceutical Industry, LC-MS, Drug Development, Heterocyclic Chemistry, Chemistry, NMR, Parallel Synthesis, Synthetic Organic..., CMC development, process chemistry, Chemistry Outsourcing, Pharmaceutical Sciences, API Scale up, Team Leadership, Team Building, Pharmacology, Pharmacokinetics, Outsourcing
Education
University of North Carolina at Chapel Hill 1995 — 1996
Post Doc., Organic Chemistry
The University of Texas at Austin 1990 — 1995
PhD, Organic Chemistry
Carnegie Mellon University 1986 — 1990
BS, Organic Chemistry
3-V Biosciences May 2013 - Present
Blanca Pharmaceuticals, LLC, Menlo Park, CA October 2012 - Present
ASW Pharmaceutical and Biotech Consulting October 2012 - Present
NuPotential, Inc. January 2013 - April 2015
Achaogen. Inc. October 2012 - April 2013
Achaogen, Inc October 2006 - September 2012
Novartis Corp., NIBR, Emeryville, CA April 2006 - October 2006
Chiron Corporation September 1996 - April 2006
Skills
Medicinal Chemistry, Drug Discovery, Drug Design, Organic Chemistry, Organic Synthesis, Biotechnology, Pharmaceutical Industry, LC-MS, Drug Development, Heterocyclic Chemistry, Chemistry, NMR, Parallel Synthesis, Synthetic Organic..., CMC development, process chemistry, Chemistry Outsourcing, Pharmaceutical Sciences, API Scale up, Team Leadership, Team Building, Pharmacology, Pharmacokinetics, Outsourcing
Education
University of North Carolina at Chapel Hill 1995 — 1996
Post Doc., Organic Chemistry
The University of Texas at Austin 1990 — 1995
PhD, Organic Chemistry
Carnegie Mellon University 1986 — 1990
BS, Organic Chemistry
Qingning Shirley Feng Qingning Shirley Feng's 3-V Biosciences Experience March 2010 - August 2013
Job Associate Scientist at Gilead Sciences
Industry Pharmaceuticals
Experience
Gilead Sciences August 2013 - Present
3-V Biosciences March 2010 - August 2013
Roche Palo Alto November 2004 - September 2009
Exelixis January 2002 - November 2004
Elan June 2000 - December 2001
Skills
Drug Discovery, HPLC, LC-MS, ADME, IND, Bioanalysis, DMPK, Assay Development, Drug Development, Mass Spectrometry, Chromatography, Biotechnology, Cell, In Vitro, Analytical Chemistry, Drug Design, Chemistry, Lead Change, Validation
Education
Clemson University
MS, Chemistry
Fudan University
BS, Chemistry
Gilead Sciences August 2013 - Present
3-V Biosciences March 2010 - August 2013
Roche Palo Alto November 2004 - September 2009
Exelixis January 2002 - November 2004
Elan June 2000 - December 2001
Skills
Drug Discovery, HPLC, LC-MS, ADME, IND, Bioanalysis, DMPK, Assay Development, Drug Development, Mass Spectrometry, Chromatography, Biotechnology, Cell, In Vitro, Analytical Chemistry, Drug Design, Chemistry, Lead Change, Validation
Education
Clemson University
MS, Chemistry
Fudan University
BS, Chemistry
Dena Minning's 3-V Biosciences Experience January 2008 - September 2010
Job Candidate for U.S. Congress in Florida's Ninth District
Industry Political Organization
Experience
U.S. Congress, Florida's Ninth District July 2015 - Present
MedExpert Consulting, Inc. July 2010 - Present
AlloCure January 2011 - September 2014
3-V Biosciences January 2008 - September 2010
Amgen September 2003 - January 2008
The Aspen Institute 2006 - 2008
MEDACorp 2002 - 2003
UCSF Medical Center 2000 - 2001
Skills
Biotechnology, Clinical Development, Oncology, Infectious Diseases, R&D, Clinical Research, Cancer, Biochemistry, Clinical Trials, Translational Research, Translational Medicine, Drug Development, Drug Discovery, Lifesciences, Pharmaceutical Industry, Biopharmaceuticals, Hematology, Executive Management, Leadership, Entrepreneurship, Due Diligence, Biodefense, Bioterrorism, Antiviral, Monoclonal Antibodies, Pharmaceuticals, Clinical Pharmacology, Stem Cells, Vaccines, Pharmacology, IND, Molecular Biology, Immunology, Biologics, Biomarkers, Cell Biology, Technology Transfer, Commercialization, Pharmaceutics, Cell, GCP, CTMS, Inflammation, FDA, CRO, Medical Writing, Internal Medicine, Protein Chemistry, Regulatory Submissions, Business Development
Education
University of California, San Francisco - School of Medicine 2000 — 2001
Residency, Internal Medicine Residency Program
Washington University in St. Louis School of Medicine 1992 — 2000
M.D., Ph.D., Medicine, Biochemistry
University of Florida 1988 — 1992
Bachelor of Science (B.S.), Biochemistry and Molecular Biology
U.S. Congress, Florida's Ninth District July 2015 - Present
MedExpert Consulting, Inc. July 2010 - Present
AlloCure January 2011 - September 2014
3-V Biosciences January 2008 - September 2010
Amgen September 2003 - January 2008
The Aspen Institute 2006 - 2008
MEDACorp 2002 - 2003
UCSF Medical Center 2000 - 2001
Skills
Biotechnology, Clinical Development, Oncology, Infectious Diseases, R&D, Clinical Research, Cancer, Biochemistry, Clinical Trials, Translational Research, Translational Medicine, Drug Development, Drug Discovery, Lifesciences, Pharmaceutical Industry, Biopharmaceuticals, Hematology, Executive Management, Leadership, Entrepreneurship, Due Diligence, Biodefense, Bioterrorism, Antiviral, Monoclonal Antibodies, Pharmaceuticals, Clinical Pharmacology, Stem Cells, Vaccines, Pharmacology, IND, Molecular Biology, Immunology, Biologics, Biomarkers, Cell Biology, Technology Transfer, Commercialization, Pharmaceutics, Cell, GCP, CTMS, Inflammation, FDA, CRO, Medical Writing, Internal Medicine, Protein Chemistry, Regulatory Submissions, Business Development
Education
University of California, San Francisco - School of Medicine 2000 — 2001
Residency, Internal Medicine Residency Program
Washington University in St. Louis School of Medicine 1992 — 2000
M.D., Ph.D., Medicine, Biochemistry
University of Florida 1988 — 1992
Bachelor of Science (B.S.), Biochemistry and Molecular Biology
Bob McDowell's 3-V Biosciences Experience November 2008 - July 2012
Job Vice President, Drug Discovery at MyoKardia
Industry Pharmaceuticals
Experience
MyoKardia July 2012 - Present
3-V BioSciences November 2008 - July 2012
Sunesis Pharmaceuticals February 2000 - August 2008
Skills
Biotechnology, Oncology, Medicinal Chemistry, Clinical Development, Biochemistry, Drug Development, IND, Pharmaceutical Industry, Cancer, Lifesciences, Organic Chemistry, Translational Medicine, Molecular Biology, Biopharmaceuticals, Cell Biology
Education
University of California, Berkeley 1980 — 1984
Doctor of Philosophy (Ph.D.), Organic Chemistry
Butler University 1976 — 1980
Bachelor's degree, Chemistry and Physics
MyoKardia July 2012 - Present
3-V BioSciences November 2008 - July 2012
Sunesis Pharmaceuticals February 2000 - August 2008
Skills
Biotechnology, Oncology, Medicinal Chemistry, Clinical Development, Biochemistry, Drug Development, IND, Pharmaceutical Industry, Cancer, Lifesciences, Organic Chemistry, Translational Medicine, Molecular Biology, Biopharmaceuticals, Cell Biology
Education
University of California, Berkeley 1980 — 1984
Doctor of Philosophy (Ph.D.), Organic Chemistry
Butler University 1976 — 1980
Bachelor's degree, Chemistry and Physics
Nathan Kozon's 3-V Biosciences Experience February 2010 - March 2010
Job DMPK Research Associate 3 at Nektar Therapeutics
Industry Pharmaceuticals
Experience
Nektar Therapeutics March 2010 - Present
3-V Biosciences February 2010 - March 2010
Arena Pharmaceuticals September 2006 - June 2009
Neurocrine Biosciences 2004 - 2006
Skills
Drug Metabolism, R&D, Mass Spectrometry, Assay Development, GLP, Biotechnology, Drug Discovery
Education
University of California, Davis 1999 — 2003
Bsc., Biological Sciences - NPB
De La Salle High School
Nektar Therapeutics March 2010 - Present
3-V Biosciences February 2010 - March 2010
Arena Pharmaceuticals September 2006 - June 2009
Neurocrine Biosciences 2004 - 2006
Skills
Drug Metabolism, R&D, Mass Spectrometry, Assay Development, GLP, Biotechnology, Drug Discovery
Education
University of California, Davis 1999 — 2003
Bsc., Biological Sciences - NPB
De La Salle High School
Satya Yendluri's 3-V Biosciences Experience October 2011 - March 2013
Job Scientist @ NIBR
Industry Biotechnology
Experience
Novartis Institutes for BioMedical Research April 2014 - Present
3-V Biosciences October 2011 - March 2013
Merck & Co.,Inc May 2006 - October 2011
Cell Genesys Inc May 2001 - May 2006
Calydon Inc August 2000 - February 2001
UC Davis April 1999 - September 2000
Skills
Assay Development, Cell Culture, High Throughput..., qPCR, Molecular Biology, Cell, ELISA, RNA isolation, Western Blotting, Immunofluorescence, DNA extraction, Cell Biology, Viruses, Cell Based Assays, FACS, Gel Electrophoresis, GraphPad Prism, Image Analysis, LIMS, Molecular Cloning, Primer Design, Site-directed..., Subcloning, Vector NTI, RNAi, Oncology, Drug Discovery, High Content Microscopy, Program Management, Optimization, Six Sigma, Soft Agar Assay, Southern, Virology
Education
University of California, Davis 1996 — 2000
BS, Genetics
Novartis Institutes for BioMedical Research April 2014 - Present
3-V Biosciences October 2011 - March 2013
Merck & Co.,Inc May 2006 - October 2011
Cell Genesys Inc May 2001 - May 2006
Calydon Inc August 2000 - February 2001
UC Davis April 1999 - September 2000
Skills
Assay Development, Cell Culture, High Throughput..., qPCR, Molecular Biology, Cell, ELISA, RNA isolation, Western Blotting, Immunofluorescence, DNA extraction, Cell Biology, Viruses, Cell Based Assays, FACS, Gel Electrophoresis, GraphPad Prism, Image Analysis, LIMS, Molecular Cloning, Primer Design, Site-directed..., Subcloning, Vector NTI, RNAi, Oncology, Drug Discovery, High Content Microscopy, Program Management, Optimization, Six Sigma, Soft Agar Assay, Southern, Virology
Education
University of California, Davis 1996 — 2000
BS, Genetics
Hanbiao Yang's 3-V Biosciences Experience April 2010 - July 2011
Job Scientist and Patent Agent at Peloton Therapeutics
Industry Pharmaceuticals
Experience
Peloton Therapeutics February 2013 - Present
Wilson Sonsini Goodrich and Rosati July 2011 - Present
3-V Biosciences April 2010 - July 2011
Roche Palo Alto September 2006 - May 2010
GSK July 1999 - September 2001
Skills
Drug Discovery, Chemistry, Medicinal Chemistry, Organic Chemistry, Total Synthesis
Education
Stanford University 2001 — 2006
PhD, Organic Chemistry
Peloton Therapeutics February 2013 - Present
Wilson Sonsini Goodrich and Rosati July 2011 - Present
3-V Biosciences April 2010 - July 2011
Roche Palo Alto September 2006 - May 2010
GSK July 1999 - September 2001
Skills
Drug Discovery, Chemistry, Medicinal Chemistry, Organic Chemistry, Total Synthesis
Education
Stanford University 2001 — 2006
PhD, Organic Chemistry
Rick Rodgers's 3-V Biosciences Experience March 2015 - Present
Job Board Member Ardelyx, Rexahn & 3V
Industry Pharmaceuticals
Experience
3-V Biosciences March 2015 - Present
Rexahn Pharmaceuticals December 2014 - Present
Ardelyx March 2014 - Present
TESARO May 2010 - August 2013
Abraxis BioScience June 2009 - February 2010
MGI Pharma January 2004 - January 2009
ADC Telecommunications 1997 - 2002
United MicroLabs 1995 - 1996
Skills
Sarbanes-Oxley Act, SEC filings, Financial Reporting, US GAAP, Due Diligence, Mergers & Acquisitions, Financial Modeling, Investor Relations, Forecasting, Mergers, Financial Analysis, Strategic Planning, Acquisition Integration
Education
University of Minnesota - Carlson School of Management 1997 — 2001
MBA, Finance
St. Cloud State University 1986 — 1990
3-V Biosciences March 2015 - Present
Rexahn Pharmaceuticals December 2014 - Present
Ardelyx March 2014 - Present
TESARO May 2010 - August 2013
Abraxis BioScience June 2009 - February 2010
MGI Pharma January 2004 - January 2009
ADC Telecommunications 1997 - 2002
United MicroLabs 1995 - 1996
Skills
Sarbanes-Oxley Act, SEC filings, Financial Reporting, US GAAP, Due Diligence, Mergers & Acquisitions, Financial Modeling, Investor Relations, Forecasting, Mergers, Financial Analysis, Strategic Planning, Acquisition Integration
Education
University of Minnesota - Carlson School of Management 1997 — 2001
MBA, Finance
St. Cloud State University 1986 — 1990
Yamini Ohol's 3-V Biosciences Experience July 2012 - Present
Job Scientist, Biology at 3V Biosciences
Industry Biotechnology
Experience
3-V Biosciences July 2012 - Present
Merck (formerly Schering-Plough/DNAX) September 2009 - June 2012
University of California, San Francisco 2002 - August 2009
Wellesley College 2000 - 2002
Skills
Molecular Biology, Biochemistry, Cell Biology, Infectious Diseases, Drug Discovery, Screening, Western Blotting, Cell Based Assays, Molecular Cloning, PCR, RT-PCR, qPCR, Tissue Culture, Transfection, Microbiology, Protein Expression, SDS-PAGE, Immunoprecipitation, Immunofluorescence, Biotechnology, Protein Chemistry, Cell, Immunoassays, Cell Culture, RNA isolation, Immunohistochemistry, Assay Development, Proteomics, In Vitro, Lifesciences, Immunology
Education
University of California, San Francisco 2002 — 2009
Ph.D.
Wellesley College 1998 — 2002
B.A.
Bombay Scottish School 1988 — 1996
3-V Biosciences July 2012 - Present
Merck (formerly Schering-Plough/DNAX) September 2009 - June 2012
University of California, San Francisco 2002 - August 2009
Wellesley College 2000 - 2002
Skills
Molecular Biology, Biochemistry, Cell Biology, Infectious Diseases, Drug Discovery, Screening, Western Blotting, Cell Based Assays, Molecular Cloning, PCR, RT-PCR, qPCR, Tissue Culture, Transfection, Microbiology, Protein Expression, SDS-PAGE, Immunoprecipitation, Immunofluorescence, Biotechnology, Protein Chemistry, Cell, Immunoassays, Cell Culture, RNA isolation, Immunohistochemistry, Assay Development, Proteomics, In Vitro, Lifesciences, Immunology
Education
University of California, San Francisco 2002 — 2009
Ph.D.
Wellesley College 1998 — 2002
B.A.
Bombay Scottish School 1988 — 1996
Samnang Tep's 3-V Biosciences Experience October 2011 - June 2013
Job Senior Research Associate at 3V Bioscience
Industry Biotechnology
Experience
3-V Biosciences October 2011 - June 2013
Merck Sharp & Dohme February 2009 - September 2011
Elan Pharmaceuticals November 2005 - January 2009
Skills
Assay Development, Drug Discovery, In Vitro, High Throughput..., LC-MS/MS, In Vivo, PK/PD, IND, Pharmacology, Cardiovascular Disease, Biomarker Development, Cell, Cell Culture, Protein Chemistry, GLP, Drug Development, Neuroscience, ELISA, Molecular Biology, Biomarkers, DMPK, Translational Research, ADME, Antibodies, Translational Medicine, Confocal Microscopy
Education
University of California, Davis
B.S., Neurobiology, Physiology, and Behavior
3-V Biosciences October 2011 - June 2013
Merck Sharp & Dohme February 2009 - September 2011
Elan Pharmaceuticals November 2005 - January 2009
Skills
Assay Development, Drug Discovery, In Vitro, High Throughput..., LC-MS/MS, In Vivo, PK/PD, IND, Pharmacology, Cardiovascular Disease, Biomarker Development, Cell, Cell Culture, Protein Chemistry, GLP, Drug Development, Neuroscience, ELISA, Molecular Biology, Biomarkers, DMPK, Translational Research, ADME, Antibodies, Translational Medicine, Confocal Microscopy
Education
University of California, Davis
B.S., Neurobiology, Physiology, and Behavior
Mohan Sivaraja's 3-V Biosciences Experience August 2010 - 2013
Job Drug Discovery Scientist
Industry Biotechnology
Experience
Verseon January 2015 - Present
Verseon February 2014 - January 2015
3-V Biosciences August 2010 - 2013
verseon 2009 - 2010
Genelabs Technologies 2005 - 2010
PPD 2001 - 2003
Ontogeny 1999 - 2001
Tularik 1994 - 1999
Harvard Medical School 1991 - 1994
Skills
Drug Discovery, Assay Development, Virology, High Throughput..., Protein Purification, Infectious Diseases, Lifesciences, In Vitro, Cancer, Protein Expression, Purification, Biomarkers, Fluorescence, Cell, Biochemistry, Life Sciences, ELISA
Education
Princeton University 1983 — 1988
PhD, Biochemistry
Indian Institute of Technology, Kanpur
Master's degree, Chemistry
Verseon January 2015 - Present
Verseon February 2014 - January 2015
3-V Biosciences August 2010 - 2013
verseon 2009 - 2010
Genelabs Technologies 2005 - 2010
PPD 2001 - 2003
Ontogeny 1999 - 2001
Tularik 1994 - 1999
Harvard Medical School 1991 - 1994
Skills
Drug Discovery, Assay Development, Virology, High Throughput..., Protein Purification, Infectious Diseases, Lifesciences, In Vitro, Cancer, Protein Expression, Purification, Biomarkers, Fluorescence, Cell, Biochemistry, Life Sciences, ELISA
Education
Princeton University 1983 — 1988
PhD, Biochemistry
Indian Institute of Technology, Kanpur
Master's degree, Chemistry
Michael Weinshelbaum's 3-V Biosciences Experience August 2010 - March 2011
Job Senior Environmental Database Developer at Cardno ENTRIX
Industry Information Services
Experience
Cardno ENTRIX September 2011 - Present
3-V Biosciences August 2010 - March 2011
Self Employed January 2009 - August 2010
Symyx Technologies October 2007 - December 2008
Elsevier MDL March 1999 - October 2007
Elsevier MDL February 1995 - March 1999
MDL Information Systems June 1993 - February 1995
Skills
Lifesciences, Data Management, Databases, Project Management, Pharmaceutical Industry, Agile Methodologies, Technical Writing, Biotechnology, Enterprise Software, Product Management, Data Analysis, Informatics, Quality Assurance, Software Documentation, Cross-functional Team..., Oracle, SQL, Testing, Management, Life Sciences
Education
Project Management Institute 2009 — 2009
PMP, Project Management
California State University-Hayward - School of Business and Economics 1988 — 1990
MBA, Finance
University of California, Berkeley
BA, Biology
Cardno ENTRIX September 2011 - Present
3-V Biosciences August 2010 - March 2011
Self Employed January 2009 - August 2010
Symyx Technologies October 2007 - December 2008
Elsevier MDL March 1999 - October 2007
Elsevier MDL February 1995 - March 1999
MDL Information Systems June 1993 - February 1995
Skills
Lifesciences, Data Management, Databases, Project Management, Pharmaceutical Industry, Agile Methodologies, Technical Writing, Biotechnology, Enterprise Software, Product Management, Data Analysis, Informatics, Quality Assurance, Software Documentation, Cross-functional Team..., Oracle, SQL, Testing, Management, Life Sciences
Education
Project Management Institute 2009 — 2009
PMP, Project Management
California State University-Hayward - School of Business and Economics 1988 — 1990
MBA, Finance
University of California, Berkeley
BA, Biology
Elisarah Sudharmadji , CPA's 3-V Biosciences Experience May 2012 - June 2013
Job at
Industry Financial Services
Experience
Lam Research March 2015 - Present
Lam Research June 2013 - March 2015
3-V Biosciences May 2012 - June 2013
3-V Biosciences June 2010 - May 2012
Ernst & Young LLP October 2008 - November 2009
Education
The University of New Mexico - Robert O. Anderson School of Management 2004 — 2008
B.S, Accounting
Lam Research March 2015 - Present
Lam Research June 2013 - March 2015
3-V Biosciences May 2012 - June 2013
3-V Biosciences June 2010 - May 2012
Ernst & Young LLP October 2008 - November 2009
Education
The University of New Mexico - Robert O. Anderson School of Management 2004 — 2008
B.S, Accounting
Deloitte
PwC
Ernst & Young
Walgreens
Procter & Gamble
KPMG
PricewaterhouseCoopers
EY